tirzepatide pancreatitis gallbladder disease warning label Ozempic: Semaglutide is a GLP-1 receptor agonist used for type 2 diabetes and cardiovascular risk reduction in selected patients, commonly causing nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and weight loss Tirzepatide is a first-in-class dual

As seen in current safety data, there hasnt been a clear link between Ozempic and diverticulitis

GLP-1RAs also show nonglycemic effects, including decreases in weight

Study 3: Immobilization Did Not Make Things Worse Critics of GLP-1 medications sometimes argue that the real danger is for patients who are sedentary or recovering from illness, where muscle wasting is already a concern

But lets take a moment to look at the bigger picturethe overall gut-GLP-1 connectionand how GLP-1 medications may affect your digestive health

While more human studies are needed, current research shows that polyphenols act as fuel for beneficial gut bacteria, helping strains like A